Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Emerging Research Reveals Important Role of Chromium Picolinate in Insulin Resistance and Chronic Disease
- Emerging Research Reveals Important Role of Chromium Picolinate in Insulin Resistance and Chronic Disease
- New Clinical Trial Adds to Body of Evidence Showing Chromium Picolinate Lowers Blood Sugar in Insulin-Treated People with Poorly-Controlled Type 2 Diabetes
- New Clinical Trial Adds to Body of Evidence Showing Chromium Picolinate Lowers Blood Sugar in Insulin-Treated People with Poorly-Controlled Type 2 Diabetes
- Harvard Study Links Low Chromium Levels to Increased Risk of Heart Disease In Men with Diabetes
Retrospective analysis from the Harvard Health Professionals Follow-up Study showed that men with diabetes and cardiovascular disease had 46% less chromium in toenails than healthy subjects.
- Harvard Study Links Low Chromium Levels to Increased Risk of Heart Disease In Men with Diabetes
Retrospective analysis from the Harvard Health Professionals Follow-up Study showed that men with diabetes and cardiovascular disease had 46% less chromium in toenails than healthy subjects.
- Harvard Study Links Low Chromium Levels to Increased Risk of Heart Disease In Men with Diabetes
Retrospective analysis from the Harvard Health Professionals Follow-up Study showed that men with diabetes and cardiovascular disease had 46% less chromium in toenails than healthy subjects.
- Harvard Study Links Low Chromium Levels to Increased Risk of Heart Disease In Men with Diabetes
Retrospective analysis from the Harvard Health Professionals Follow-up Study showed that men with diabetes and cardiovascular disease had 46% less chromium in toenails than healthy subjects.
- Harvard Study Links Low Chromium Levels to Increased Risk of Heart Disease In Men with Diabetes
Retrospective analysis from the Harvard Health Professionals Follow-up Study showed that men with diabetes and cardiovascular disease had 46% less chromium in toenails than healthy subjects.
- Harvard Study Links Low Chromium Levels to Increased Risk of Heart Disease In Men with Diabetes
Retrospective analysis from the Harvard Health Professionals Follow-up Study showed that men with diabetes and cardiovascular disease had 46% less chromium in toenails than healthy subjects.
- New Clinical Study Shows Walnuts Protective for People with Type 2 Diabetes
Australian study published in the December 2004 issue of Diabetes Care, shows that, for patients with type 2 diabetes, a whole foods diet including walnuts can reduce LDL "bad" cholesterol by 10%.
- New Clinical Study Shows Walnuts Protective for People with Type 2 Diabetes
Australian study published in the December 2004 issue of Diabetes Care, shows that, for patients with type 2 diabetes, a whole foods diet including walnuts can reduce LDL "bad" cholesterol by 10%.
- New Clinical Study Shows Walnuts Protective for People with Type 2 Diabetes
Australian study published in the December 2004 issue of Diabetes Care, shows that, for patients with type 2 diabetes, a whole foods diet including walnuts can reduce LDL "bad" cholesterol by 10%.
- Nutrition 21 and XL Health Report Positive Results for Diachrome Clinical Trial in People with Type 2 Diabetes
Companies announce results of 453 patient multi-center trial, the largest U.S. study to demonstrate the health benefits of a chromium-based intervention for diabetes.
- Nutrition 21 and XL Health Report Positive Results for Diachrome Clinical Trial in People with Type 2 Diabetes
Companies announce results of 453 patient multi-center trial, the largest U.S. study to demonstrate the health benefits of a chromium-based intervention for diabetes.
- Nutrition 21 and XL Health Report Positive Results for Diachrome Clinical Trial in People with Type 2 Diabetes
Companies announce results of 453 patient multi-center trial, the largest U.S. study to demonstrate the health benefits of a chromium-based intervention for diabetes.
- Nutrition 21 and XL Health Report Positive Results for Diachrome Clinical Trial in People with Type 2 Diabetes
Companies announce results of 453 patient multi-center trial, the largest U.S. study to demonstrate the health benefits of a chromium-based intervention for diabetes.
- Nutrition 21 and XL Health Report Positive Results for Diachrome Clinical Trial in People with Type 2 Diabetes
Companies announce results of 453 patient multi-center trial, the largest U.S. study to demonstrate the health benefits of a chromium-based intervention for diabetes.
- Nutrition 21 and XL Health Report Positive Results for Diachrome Clinical Trial in People with Type 2 Diabetes
Companies announce results of 453 patient multi-center trial, the largest U.S. study to demonstrate the health benefits of a chromium-based intervention for diabetes.
- Poor Prenatal Nutrition Permanently Damages Function of Insulin-producing Cells in the Pancreas
Mice studies indicate that poor prenatal nutrition impairs the pancreas's ability to later secrete enough insulin in response to blood glucose, leading to elevated risk of Type 2 diabetes later in life.
- Poor Prenatal Nutrition Permanently Damages Function of Insulin-producing Cells in the Pancreas
Mice studies indicate that poor prenatal nutrition impairs the pancreas's ability to later secrete enough insulin in response to blood glucose, leading to elevated risk of Type 2 diabetes later in life.
- Poor Prenatal Nutrition Permanently Damages Function of Insulin-producing Cells in the Pancreas
Mice studies indicate that poor prenatal nutrition impairs the pancreas's ability to later secrete enough insulin in response to blood glucose, leading to elevated risk of Type 2 diabetes later in life.
- Poor Prenatal Nutrition Permanently Damages Function of Insulin-producing Cells in the Pancreas
Mice studies indicate that poor prenatal nutrition impairs the pancreas's ability to later secrete enough insulin in response to blood glucose, leading to elevated risk of Type 2 diabetes later in life.
- Poor Prenatal Nutrition Permanently Damages Function of Insulin-producing Cells in the Pancreas
Mice studies indicate that poor prenatal nutrition impairs the pancreas's ability to later secrete enough insulin in response to blood glucose, leading to elevated risk of Type 2 diabetes later in life.
- New Study Finds Cocoa Flavanols May Lower Blood Pressure, Improve Insulin Response
Study from Italy's University of L'Aquila, published in this month's American Journal of Clinical Nutrition, is consitent with previous research that suggests that naturally occurring flavanol compounds found in certain cocoa and chocolates may provide heart health benefits.
- New Study Finds Cocoa Flavanols May Lower Blood Pressure, Improve Insulin Response
Study from Italy's University of L'Aquila, published in this month's American Journal of Clinical Nutrition, is consitent with previous research that suggests that naturally occurring flavanol compounds found in certain cocoa and chocolates may provide heart health benefits.
- New Study Finds Cocoa Flavanols May Lower Blood Pressure, Improve Insulin Response
Study from Italy's University of L'Aquila, published in this month's American Journal of Clinical Nutrition, is consitent with previous research that suggests that naturally occurring flavanol compounds found in certain cocoa and chocolates may provide heart health benefits.
- New Study Finds Cocoa Flavanols May Lower Blood Pressure, Improve Insulin Response
Study from Italy's University of L'Aquila, published in this month's American Journal of Clinical Nutrition, is consitent with previous research that suggests that naturally occurring flavanol compounds found in certain cocoa and chocolates may provide heart health benefits.
- Study on Pharmanex Tegreen 97(R) Finds Benefits in Blood Sugar Control and Weight Loss
Study recently presented at the American Heart Association's Sixth Annual Conference indicates that Tegreen 97(R) provides blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects.
- Study on Pharmanex Tegreen 97(R) Finds Benefits in Blood Sugar Control and Weight Loss
Study recently presented at the American Heart Association's Sixth Annual Conference indicates that Tegreen 97(R) provides blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects.
- Study on Pharmanex Tegreen 97(R) Finds Benefits in Blood Sugar Control and Weight Loss
Study recently presented at the American Heart Association's Sixth Annual Conference indicates that Tegreen 97(R) provides blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects.
- Study on Pharmanex Tegreen 97(R) Finds Benefits in Blood Sugar Control and Weight Loss
Study recently presented at the American Heart Association's Sixth Annual Conference indicates that Tegreen 97(R) provides blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects.
- Study on Pharmanex Tegreen 97(R) Finds Benefits in Blood Sugar Control and Weight Loss
Study recently presented at the American Heart Association's Sixth Annual Conference indicates that Tegreen 97(R) provides blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects.
- Study on Pharmanex Tegreen 97(R) Finds Benefits in Blood Sugar Control and Weight Loss
Study recently presented at the American Heart Association's Sixth Annual Conference indicates that Tegreen 97(R) provides blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects.
- New Clinical Trial Shows Diachrome Improves Diabetes Care for Patients with Poorly-Controlled Blood Sugar Levels on Prescription Medications
Results from a new clinical trial that show daily supplementation with Diachrome(R)can improve uncontrolled blood sugar levels and cardiovascular risk factors in people with type 2 diabetes on prescription medications in a managed care setting; study evaluated 369 subjects and was presented at the American Diabetes Association (ADA) 65th Annual Scientific Sessions in San Diego, CA.
- Tate & Lyle Interim Results Announcement 2009
Tate & Lyle has announced their 2009 Interim results, reporting the Group's performance, before the impact of exchange translation, remains on track to meet our expectations for the full year.
- NPI Daily - Top of The News for Nov. 6, 2009 - National Organic Standards Board Votes to Crack Down on Organic Personal Care Cheaters
Nature's Sunshine Products Reports FY09 Q3 Operating Results; SunOpta Announces FY09 Q3 Results; Tate & Lyle Interim Results Announcement 2009; NOW Foods Receives the 2009 Illinois Governor's Sustainability Award; Transport-C Supports Vitamin Angels at SSW; Cantox at Supplyside West; New Support Showing Immunoglobulin Supplementation Enhances Immune System; FDA Warning: Over-the-Counter Sex Enhancement Drug May Cause 'Dangerously' Low Blood Pressure; EPAX AS Achieves 'Friend of the Sea' Certification; National Organic Standards Board Votes to Crack Down on Organic Personal Care Cheaters; Fast-C™ At SupplySide West: US Clinical Trials Data Available In Booth ; Nutty Flavor & Healthy Boost of Omega-3 Make Hemp Seed an Ideal Ingredient; DSM's tensVida® Recognized for Innovative Development; Nutrition 21 Announces Addition of Innovative New Probiotic + Omega-3 Fish Oil Combination Product; Glanbia Nutritionals Offers More Than Ingredients for Nutritional Beverages; Whole Foods Market(R) Offers Natural Solutions to Help Build Up Body Defenses With Immune System Support; Doug Reyes Joins Embria as Regional Sales Manager; Michael F. Hines Joins Board of General Nutrition Centers, Inc.; Dr. Arnold Hirsch Celebrates 50th Anniversary with the American Chemical Society
- NPI Daily - Top of The News for Nov. 6, 2009 - National Organic Standards Board Votes to Crack Down on Organic Personal Care Cheaters
Nature's Sunshine Products Reports FY09 Q3 Operating Results; SunOpta Announces FY09 Q3 Results; Tate & Lyle Interim Results Announcement 2009; NOW Foods Receives the 2009 Illinois Governor's Sustainability Award; Transport-C Supports Vitamin Angels at SSW; Cantox at Supplyside West; New Support Showing Immunoglobulin Supplementation Enhances Immune System; FDA Warning: Over-the-Counter Sex Enhancement Drug May Cause 'Dangerously' Low Blood Pressure; EPAX AS Achieves 'Friend of the Sea' Certification; National Organic Standards Board Votes to Crack Down on Organic Personal Care Cheaters; Fast-C™ At SupplySide West: US Clinical Trials Data Available In Booth ; Nutty Flavor & Healthy Boost of Omega-3 Make Hemp Seed an Ideal Ingredient; DSM's tensVida® Recognized for Innovative Development; Nutrition 21 Announces Addition of Innovative New Probiotic + Omega-3 Fish Oil Combination Product; Glanbia Nutritionals Offers More Than Ingredients for Nutritional Beverages; Whole Foods Market(R) Offers Natural Solutions to Help Build Up Body Defenses With Immune System Support; Doug Reyes Joins Embria as Regional Sales Manager; Michael F. Hines Joins Board of General Nutrition Centers, Inc.; Dr. Arnold Hirsch Celebrates 50th Anniversary with the American Chemical Society
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Taming Fear of the H1N1 Flu Vaccine
- Taming Fear of the H1N1 Flu Vaccine
- Natural Cold and Flu Remedies: Do They Help?
- Natural Cold and Flu Remedies: Do They Help?
- Exercise as Pain Therapy
- Exercise as Pain Therapy
|
Minneapolis, USA – FenuLife®, a new health ingredient from Acatris Inc., was shown to reduce blood sugar levels in both non-diabetic and type-II diabetic subjects. FenuLife contains the highest concentration of fenugreek galactomannan, which can balance sugar absorption in the small intestine and help individuals avoid large spikes in blood sugar levels following meals. Two separate studies were conducted to investigate the effects of FenuLife on glycemic response. Both reported a reduction in blood sugar levels with different doses of FenuLife.
Researchers at Glycaemic Index Testing Inc. in Toronto, Canada tested 4 different dosages of FenuLife and compared it with two other fibre sources: psyllium husk powder and oat brand concentrate. A group of 10 non-diabetic subjects consumed a 50g glucose solution enriched with either of the indicated fibres. Finger prick capillary blood was taken for glucose analysis at 15, 30,45, 60, 90 and 120 minutes after the start of the meal. A reduction in blood sugar levels was reported at all dosages, however most significantly with the highest dose of FenuLife, thus establishing a clear dose-response effect. Neither psyllium husk powder or oat bran concentrate showed any effect at the tested dosages.
In a second study, researchers at Kyourin University in Japan studied the effect of different doses of FenuLife on fasting blood sugar levels in type-II diabetic patients. The test group was divided in two sub-groups based on the severity of their diabetes. FenuLife reduced fasting blood sugar levels in subjects with light/moderate diabetes. Once desired levels were obtained, a reduced dose of FenuLife maintained the improved fasting blood sugar levels. In subjects with severe diabetes, FenuLife created a complementary effect on the reduction of fasting blood sugar levels along with the use of conventional diabetic drugs.
Acatris Inc. develops and markets innovative health ingredients supported by science, including SoyLife®, FenuLife® and LinumLifeTM.
Source: Acatris Inc. USA |